Impact of remdesivir modifications on human HINT1 binding – A structural and functional study in the remdesivir activation pathway；Publication Name: Structure (London, England : 1993)；Publication Date: 2026-05-25；PMID: 42184828；DOI: 10.1016/j.str.2026.04.015
Efectividad y seguridad de remdesivir y nirmatrelvir-ritonavir en la COVID-19 leve-moderada en los servicios de urgencia hospitalaria españoles；Publication Name: Medicina Clínica；Publication Date: 2025-08；PMID: 40412101；DOI: 10.1016/j.medcli.2025.106912
Successful treatment of prolonged COVID-19 with remdesivir and nirmatrelvir/ritonavir in a patient with a history of diffuse large B-cell lymphoma: a case report；Publication Name: Journal of the Egyptian National Cancer Institute；Publication Date: 2025-06-30；PMID: 40583098；DOI: 10.1186/s43046-025-00291-1
Eco-friendly spectrofluorimetric determination of remdesivir in the presence of its metabolite in human plasma for therapeutic monitoring in COVID-19 patients；Publication Name: Scientific Reports；Publication Date: 2025-06-23；PMID: 40550830；DOI: 10.1038/s41598-025-05198-4
Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different?；Publication Name: Viruses；Publication Date: 2025-06-10；PMID: 40573427；DOI: 10.3390/v17060836
Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19；Publication Name: Clinical Pharmacokinetics；Publication Date: 2025-04-22；PMID: 40261493；DOI: 10.1007/s40262-025-01496-2
High‐dose induction therapy and treatment termination criteria for feline infectious peritonitis with remdesivir, GS‐441524 and adjunctive mefloquine: 46 cases (2023)；Publication Name: The Journal of small animal practice；Publication Date: 2025-04-18；PMID: 40251466；DOI: 10.1111/jsap.13869
Treatment of feline infectious peritonitis in cats with molnupiravir: clinical observations and outcomes for 54 cases；Publication Name: Australian Veterinary Journal；Publication Date: 2025-04-15；PMID: 40234239；DOI: 10.1111/avj.13433
Pharmacokinetics of GS‐441524 following intravenous remdesivir in six cats and results of therapeutic drug monitoring during treatment of feline infectious peritonitis: 22 cases (2021–2024)；Publication Name: The Journal of small animal practice；Publication Date: 2025-03-17；PMID: 40097914；DOI: 10.1111/jsap.13849
Remdesivir is active in vitro against tick-borne encephalitis virus and selects for resistance mutations in the viral RNA-dependent RNA polymerase；Publication Name: Infectious diseases (London, England)；Publication Date: 2025-02-20；PMID: 39973341；DOI: 10.1080/23744235.2025.2468510